02142 News
Harbour BioMed Acquires 3.8% Stake in Spruce Biosciences
Harbour BioMed Acquires 3.8% of Spruce Biosciences, Enhancing Strategic Partnership
Harbour BioMed Partners with Lannacheng for Next-Gen Radionuclide Drug Development
Harbour BioMed Enters Long-Term Strategic Collaboration with Lannacheng to Advance Next-Generation Radionuclide Drug Conjugates
Harbour BioMed Partners with Bristol Myers Squibb for $1.125 Billion Antibody Collaboration
HBM HOLDINGS-B Forms Strategic Partnership with Bristol Myers Squibb, Potentially Earning Up to US$1.035B in Milestone Payments and Royalties
HBM HOLDINGS-B Aims to Generate $512M Through Share Placement at 9.5% Discount
02142 Events
No data
02142 Monitor News
No data
02142 Earnings Analysis